Postpartum Exercise Cuts Odds of Postpartum Depression
By Lori Solomon HealthDay Reporter
THURSDAY, Nov. 7, 2024 -- Odds of postpartum depression are reduced by 45 percent in individuals who engaged in postpartum exercise, according to a review published online Nov. 5 in the British Journal of Sports Medicine.
Andy Deprato, from the University of Alberta in Edmonton, Canada, and colleagues conducted a systematic literature review to examine the influence of postpartum exercise on maternal depression and anxiety.
Based on 35 studies (4,072 individuals), the researchers found with moderate-certainty evidence that exercise-only interventions reduced the severity of postpartum depressive symptoms (19 randomized controlled trials [RCTs]; standardized mean differences [SMDs]: −0.52; I2 = 86 percent; moderate effect size) and anxiety symptoms (two RCTs; SMD: −0.25; I2 = 0 percent; small effect size) and the odds of postpartum depression (four RCTs; odds ratio, 0.55; I2 = 0 percent) versus no exercise. Postpartum individuals needed to accumulate at least 350 MET-minutes/week of exercise (e.g., 80 minutes of moderate-intensity exercise such as brisk walking, water aerobics, stationary cycling, or resistance training) to achieve at least a moderate reduction in the severity of postpartum depressive symptoms.
"These data support the engagement in postpartum physical activity to prevent or improve depressive symptoms as a low-cost and acceptable intervention," the authors write.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2024-11-09 00:00
Read more
- America's Epidemic of STDs May Finally Be Slowing
- CDC Lowers Age for First Pneumococcal Vaccine to 50
- Dapirolizumab Pegol Phase 3 Data Presented at the American College of Rheumatology Shows Significant Reduction in Systemic Lupus Erythematosus Disease Activity
- FDA Approves Kebilidi (eladocagene exuparvovec-tneq) Gene Therapy for the Treatment of AADC Deficiency
- More Than Half of Heat Deaths Can Be Blamed on Global Warming: Study
- Improvement Seen in Some Features of PCOS With Weight Loss Interventions
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions